Passage BIO, Inc. — Director's Dealing 2022

Jun 1, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Passage BIO, Inc. (PASG)
CIK: 0001787297
Period of Report: 2022-05-31

Reporting Person: GOWEN MAXINE (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-05-31	Stock Option (Right to Buy)	$1.80	A	40000	Acquired	2032-05-30	Common Stock (40000)	Direct

Footnotes

F1: The stock option vests in ratable increments of 1/12 of the total award on each monthly anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer on each vesting date.